Seeyond’s Novavax NVAX Stock Holding History

Seeyond’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2,334	Closed	-$120K	–	611
2022 Q2	$120K	Sell	2,334 -47	-2%	-$2.44K	0.01%	558
2022 Q1	$175K	Sell	2,381 -48	-2%	-$4.28K	0.02%	550
2021 Q4	$347K	Sell	2,429 -1,410	-37%	-$242K	0.03%	525
2021 Q3	$795K	Buy	+3,839	New	+$846K	0.08%	388

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Seeyond's NVAX Position: Q3 2022 in Review

Seeyond sold out of Novavax (NVAX) in Q3 2022, closing a stake of 2,334 shares — an estimated $120K sold.

Seeyond first reported a position in NVAX in Q3 2021 and held it in 4 quarters. The position peaked at $795K in Q3 2021. 253 funds tracked by Wall St. Rank hold NVAX as of Q3 2022.

Seeyond reported no remaining Novavax position as of Q3 2022 after selling out during the quarter.
Seeyond sold 2,334 Novavax shares in Q3 2022, an estimated $120K.
Seeyond first reported a position in Novavax in Q3 2021 and held it in 4 quarters.
Seeyond's Novavax position peaked at $795K in Q3 2021.
253 funds tracked by Wall St. Rank held Novavax as of Q3 2022.

Based on Seeyond's 13F filing for Q3 2022, filed 14 Nov 2022.